Oncologic outcomes after secondary surgery in recurrent clear-cell carcinoma of the ovary

@article{Kajiyama2019OncologicOA,
  title={Oncologic outcomes after secondary surgery in recurrent clear-cell carcinoma of the ovary},
  author={H. Kajiyama and S. Suzuki and Nobuhisa Yoshikawa and M. Kawai and K. Shibata and T. Nagasaka and F. Kikkawa},
  journal={International Journal of Gynecological Cancer},
  year={2019},
  volume={29},
  pages={910 - 915}
}
Objective Complete tumor resection is considered essential in the management of patients with ovarian clear-cell carcinoma. There is a debate regarding whether patients with recurrent ovarian clear-cell carcinoma benefit from secondary cytoreductive surgery. Methods Details of patients with clear-cell carcinoma were collected by the Tokai Ovarian Tumor Study Group (Nagoya University Hospital and 13 affiliated institutions) and evaluated between January 1990 and December 2015. Histology was… Expand
Updates of Pathogenesis, Diagnostic and Therapeutic Perspectives for Ovarian Clear Cell Carcinoma
CMAR_A_242129 913..919

References

SHOWING 1-10 OF 24 REFERENCES
Postrecurrent Oncologic Outcome of Patients With Ovarian Clear Cell Carcinoma
Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients?
When should Surgery be used for Recurrent Ovarian Carcinoma?
Ovarian clear cell adenocarcinoma.
Surgical cytoreduction for recurrent epithelial ovarian cancer.
Clinical characteristics of clear cell carcinoma of the ovary.
Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging
...
1
2
3
...